Table 2.
Characteristics of individual patients
|
No-TACE | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Patient Number | Age | Gender | Etiology | AFP | # Tumors at Dx | Size (cm) pre-op | Within Milan | Growth rate (cm/mo.) | Largest tumor dia by path | Days to Transplant* | Recur | Time to Recur |
Reasons not to TACE |
||||
| A | B | C | D | E | |||||||||||||
| N1 |
62 |
F |
HCV |
20 |
2 |
1.9, 1.6 |
Y |
N/A |
1.6 |
49 |
N |
N/A |
X |
|
|
|
|
| N2 |
48 |
M |
HCV |
13 |
1 |
1.9 |
Y |
N/A |
2 |
340 |
N |
N/A |
X |
|
|
|
|
| N3 |
49 |
F |
HCV |
1207 |
3 |
1.3, 2.0, 2.5 |
Y |
N/A |
3.4 |
188 |
N |
N/A |
X |
|
|
|
|
| N4 |
52 |
F |
HCV |
107 |
2 |
1.0, 2.1 |
Y |
N/A |
2.3 |
160 |
N |
N/A |
X |
|
|
|
|
| N5 |
65 |
M |
HCV |
5.3 |
2 |
N/A |
N/A |
N/A |
1.1 |
12 |
N |
N/A |
|
|
|
X |
|
| N6 |
56 |
M |
HBV |
4 |
1 |
4.8 |
Y |
N/A |
3.5 |
59 |
N |
N/A |
X |
|
|
|
|
| N7 |
68 |
M |
HCV |
1327 |
2 |
1.4, 2.6 |
Y |
0.12 |
2.8 |
205 |
N |
N/A |
|
|
|
|
X |
| N8 |
46 |
F |
HCV |
2809 |
1 |
3.8 |
Y |
0.2 |
6 |
115 |
N |
N/A |
X |
|
X |
|
|
| N9 |
48 |
M |
HCV |
686 |
1 |
3 |
Y |
0.4 |
3.6 |
116 |
N |
N/A |
X |
|
|
|
|
| N10 |
53 |
M |
HCV |
3 |
1 |
1.5 |
Y |
0.1 |
2.5 |
190 |
N |
N/A |
X |
|
|
|
|
| N11 |
45 |
M |
HCV |
4 |
1 |
5.4 |
N |
N/A |
5.1 |
45 |
N |
N/A |
|
X |
|
|
|
| N12 |
57 |
M |
HCV |
6 |
1 |
2.8 |
Y |
N/A |
4 |
41 |
Y |
24mo. |
X |
|
|
|
|
| N13 |
55 |
M |
HCV |
11 |
2 |
0.9, 1.6 |
Y |
N/A |
2.3 |
38 |
N |
N/A |
X |
|
|
|
|
| N14 |
49 |
M |
HCV |
7 |
1 |
5.3 |
N |
N/A |
5.5 |
87 |
N |
N/A |
|
X |
|
|
|
| N15 |
53 |
M |
HCV |
2461 |
1 |
2.8 |
Y |
N/A |
5 |
95 |
N |
N/A |
X |
|
|
|
|
| N16 |
55 |
M |
HCV |
7 |
2 |
1.0, 0.8 |
Y |
N/A |
1 |
0 |
N |
N/A |
|
|
|
X |
|
| N17 |
52 |
M |
HCV |
18 |
1 |
2.5 |
Y |
N/A |
3.1 |
128 |
N |
N/A |
X |
|
X |
|
|
| N18 |
56 |
F |
HCV |
19 |
1 |
3.3 |
Y |
N/A |
3.5 |
117 |
N |
N/A |
X |
|
X |
|
|
| N19 |
68 |
M |
HCV |
9 |
2 |
2.2, 1.6 |
Y |
0 |
2 |
377 |
N |
N/A |
X |
|
X |
|
|
| N20 |
56 |
M |
HCV |
7 |
1 |
N/A |
N/A |
N/A |
1 |
0 |
N |
N/A |
|
|
|
X |
|
| N21 |
53 |
M |
PSC |
40 |
2 |
N/A |
N/A |
N/A |
0.3 |
0 |
N |
N/A |
|
|
|
X |
|
| N22 |
64 |
M |
HCV |
20 |
1 |
2.1 |
Y |
N/A |
3.5 |
179 |
N |
N/A |
X |
|
|
|
|
| N23 | 49 | M | HCV | 3.6 | 1 | N/A | N/A | N/A | 1.5 | 0 | N | N/A | X | ||||
A = Patient was within Milan.
B = Outside Milan but eligible for transplant by MELD with a short waiting time expected.
C = Patient could not tolerate procedure.
D = Tumor not appreciated pre-op.
E = Procedure planned, not able to perform prior to transplant.
* = Days from HCC diagnosis to transplant.